Charlottesville, VA (PRWEB) May 14, 2012
OpenQ, a leading provider of solutions compliantly connecting Life Science companies to medical networks, has announced a new addition to its Compliance Advisory Board. Michael Williams, MD, the Byrd S. Leavell Professor of Medicine and Professor of Pathology and Chief, Hematologic Malignancies Section of the Hematology/Oncology Division at the University Of Virginia School Of Medicine has joined the group. Dr. Williams brings with him an extensive background as a physician, an educator, and a Key Opinion Leader (KOL).
Regulatory compliance has emerged as one of the most important issues facing the Life Science industry. To address this critical consideration and provide expert insight into the relationships between Life Science Companies and outside professionals, OpenQ formed their Compliance Advisory Board. Insight from the board has proven invaluable when delivering some of the industry’s most advanced solutions – including software, data, and professional services.
“Dr. Williams is a great addition to our Compliance Advisory Board. His perspective as a Key Opinion leader is a fantastic counterpoint to the existing industry perspectives on our Board,” stated Jim Zuffoletti, President, OpenQ. “We are all very excited to be working with him. Dr. Williams’ input will help us continue to develop extremely innovative and intuitive solutions for our customers.”
“Collaboration between Industry and Medicine is a critical part of bringing innovative new treatments to our patients,” shared Dr. Williams. “Working with OpenQ is a great opportunity to help develop solutions promoting this collaboration while ensuring the highest standards of regulatory compliance.”
Michael Williams, MD. Biography
Dr. Williams received his MD from the University of Cincinnati College of Medicine and a Master of Science in Microbiology from the Harvard School of Public Health. He completed his Medicine residency, Chief Residency, and Fellowship in Hematology/Oncology at the University of Virginia Health System in Charlottesville, where he joined the faculty in 1986. He currently serves as Chief of the Hematologic Malignancies Section in the UVA Cancer Center and the Hematology/Oncology Division.
Dr. Williams’ research interests are in the pathogenesis and immunotherapy of non-Hodgkin lymphoma and CLL, and in the clinical development of new therapeutic approaches for hematologic malignancies. He serves on the Scientific Advisory Board of the Lymphoma Research Foundation, Chaired the Executive Committee for the LRF Mantle Cell Lymphoma Consortium 2005-10, and is a member of the Scientific Advisory Board of the European Mantle Cell Lymphoma Network. Dr. Williams is Chair of the Hematology Subspecialty Board of the American Board of Internal Medicine. He is vice-chair of the Lymphoma Core Committee of the Eastern Cooperative Oncology Group, and participates regularly in national and international programs devoted to education and research in lymphoma and hematologic malignancies.
Contact: Tracy England, Vice President, Marketing, OpenQ 434-466-8078 or email@example.com
Based in Charlottesville, Virginia, OpenQ helps Life Sciences companies compliantly collaborate with medical networks to reach healthcare providers (HCPs). OpenQ’s solutions combine Big Data with expert validation and software applications to deliver actionable information that mitigates compliance risks, while leveraging the latest cloud-based and mobile applications to improve compliant medical network access, collaboration and management. The Company offers award-winning solutions for KOL Management, Medical Affairs Programs, Study Management & Grant Funding, and Speaker Programs. To learn more about OpenQ’s offerings, visit http://www.OpenQ.com.
410A E. Main St. Charlottesville, VA 22902
© 2012 OpenQ, Inc.